Deblander A

References (1)

Title : Patient and caregiver outcomes after 6 +\/- 1.5-months of rivastigmine therapy for mild-to-moderate Alzheimer's disease: the Belgian FExT study - Mets_2007_Curr.Med.Res.Opin_23_2485
Author(s) : Mets T , Vandewoude M , Jacquy J , Deblander A , MacDonald K , Sloesen A , Abraham I
Ref : Curr Med Res Opin , 23 :2485 , 2007
Abstract : Mets_2007_Curr.Med.Res.Opin_23_2485
ESTHER : Mets_2007_Curr.Med.Res.Opin_23_2485
PubMedSearch : Mets_2007_Curr.Med.Res.Opin_23_2485
PubMedID: 17784995